LZIC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.056800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.834000E-01
Normal-vs-Stage2
9.273600E-01
Normal-vs-Stage3
6.808000E-02
Normal-vs-Stage4
2.462400E-01
Stage1-vs-Stage2
7.051000E-01
Stage1-vs-Stage3
1.774430E-01
Stage1-vs-Stage4
7.751800E-02
Stage2-vs-Stage3
1.212020E-01
Stage2-vs-Stage4
7.422900E-03
Stage3-vs-Stage4
4.578500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.863400E-01
Normal-vs-AfricanAmerican
4.580800E-01
Normal-vs-Asian
7.108400E-01
Caucasian-vs-AfricanAmerican
2.589400E-01
Caucasian-vs-Asian
5.104600E-01
AfricanAmerican-vs-Asian
2.552000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.503400E-01
Normal-vs-Female
9.389400E-01
Male-vs-Female
1.714150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.404800E-01
Normal-vs-Age(41-60Yrs)
7.272800E-01
Normal-vs-Age(61-80Yrs)
7.313000E-01
Normal-vs-Age(81-100Yrs)
4.066800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.394400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.834800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.060600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.287920E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.217700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.016000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.454200E-01
Normal-vs-Daily Drinker
6.981400E-01
Normal-vs-Weekly Drinker
5.615400E-01
Normal-vs-Occasional Drinker
7.501800E-01
Normal-vs-Social Drinker
9.364400E-01
Non Drinker-vs-Daily Drinker
7.208800E-01
Non Drinker-vs-Weekly Drinker
9.948400E-01
Non Drinker-vs-Occasional Drinker
1.263950E-01
Non Drinker-vs-Social Drinker
3.166600E-01
Daily Drinker-vs-Weekly Drinker
7.320400E-01
Daily Drinker-vs-Occasional Drinker
1.902450E-01
Daily Drinker-vs-Social Drinker
4.367400E-01
Weekly Drinker-vs-Occasional Drinker
1.601410E-01
Weekly Drinker-vs-Social Drinker
3.429200E-01
Occasional Drinker-vs-Social Drinker
6.812200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.675400E-01
Normal-vs-Grade 2
8.694000E-01
Normal-vs-Grade 3
8.330400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.845970E-01
Grade 1-vs-Grade 3
9.752100E-02
Grade 1-vs-Grade 4
9.675400E-01
Grade 2-vs-Grade 3
5.525000E-01
Grade 2-vs-Grade 4
8.694000E-01
Grade 3-vs-Grade 4
8.330400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.192800E-01
Normal-vs-NonDiabetic
8.207800E-01
Diabetic-vs-NonDiabetic
6.801400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.482800E-01
Normal-vs-NoPancreatitis
9.024000E-01
Pancreatitis-vs-NoPancreatitis
7.050100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.748200E-01
Normal-vs-N1
9.783400E-01
N0-vs-N1
4.233000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.661800E-01
Normal-vs-TP53-NonMutant
8.179800E-01
TP53-Mutant-vs-TP53-NonMutant
2.518100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
